跳至主要内容
临床试验/CTRI/2022/12/048189
CTRI/2022/12/048189已完成不适用

A community-based study of prevalence of skin disorders in semi-urban and urban Telangana State

Pfizer Inc1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2023年2月1日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
Pfizer Inc
入组人数
2,000
试验地点
1
主要终点
we aim to determine the prevalence of skin disorders in urban and semi urban communities and their impact on quality of life.

研究概览

简要总结

Skin diseases contributed about 2% of the global burden of diseases measured in Disease Adjusted Life Years (DALYs) (1). The prevention and management of skin diseases received less attention in the past decades due to low mortality rates. However, a recent Global Burden of Disease Study finding revealed that skin diseases rank 18 in top 20 diseases in terms of DALYs and is fourth leading cause of nonfatal disease burden (2). Further, skin diseases increase clinical depression and anxiety. The prevalence and pattern of skin diseases are influenced by the overall ecosystem of the region including sociocultural milieu, topography, nutrition, genetics etc.

In India, skin diseases have been profiled through hospital-based studies with low levels of prevalence (3-7) as compared to community-level. The prevalence varied from 4.2% to 11.6% in the general population. However, high prevalence has been reported (30%–40%) in pediatric population (8, 9) and 60% in a community-based survey in the central India (10). There is a dearth of data about prevalence in skin diseases among semi-urban/rural communities in Telangana.

研究设计

研究类型
Observational

入排标准

年龄范围
2.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • 1.Subjects age 2 years and above 2.Subjects who have skin disorders 3.Able to provide informed consent/ assent (in case of children).
  • 4.Subjects who reside in the study area (for at least 6 months).

排除标准

  • 1.Subjects with no skin disorders.
  • 2.Subjects below the age of 2 years 3.Subjects unable to participate in study related procedures 4.Subjects unwilling or unable to provide informed consent/assent 5.Subjects who do not reside in the area (at 6 months) and/or are unlikely to reside in the area until end of December 2023.

结局指标

主要结局

we aim to determine the prevalence of skin disorders in urban and semi urban communities and their impact on quality of life.

时间窗: 12 to 13 months

次要结局

  • •To determine impact on quality of life due to skin disorders(•To explore influence of predisposing conditions including influence of geography on skin disorders and quality of life)

研究者

发起方
Pfizer Inc
申办方类型
Pharmaceutical industry-Global

研究点 (1)

Loading locations...

相似试验

A community-based study of prevalence of skin... | 临床试验